Professor, Radiation Oncology, Vanderbilt University School of Medicine
Radiation Oncology
Dr. Anuradha Chakravarthy, MD
|
|
Give Review
Doctor Anuradha Chakravarthy, MD works in the field of Radiation Oncology. He researched medicine at George Washington University School of Medicine. George Washington University School of Medicine has a rank of 67 in research and a 0 in primary care He over the years received 3 awards: "America's Top Doctors", "Nashville Lifestyles Magazine" and "America's Top Doctors for Cancer". Anuradha Chakravarthy is a published doctor and has 44 publications published. The lastest was: 'CT number distribution and its association with local control and as a marker of lung tumor response to radiation.' Anuradha Chakravarthy accepts Medicare.
Publications
- Predicting the Response of Breast Cancer to Neoadjuvant Therapy Using a Mechanically Coupled Reaction-Diffusion Model.
- Longitudinal, intermodality registration of quantitative Breast PET and MRI data acquired before and during neoadjuvant chemotherapy: Preliminary results.
- A randomized placebo-controlled pilot study of the impact of healing touch on fatigue in breast Cancer patients undergoing radiation therapy.
- Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.
- A mechanically coupled reaction-diffusion model for predicting the response of Breast tumors to neoadjuvant chemotherapy.
- Pattern of breast Cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinoma.
- DCE-MRI Analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findings.
- Machine learning for predicting the response of breast Cancer to neoadjuvant chemotherapy.
- Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
- Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenoCarcinoma.
- Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in coloRectal carcinoma.
- Failure of high-dose i.v. gammaglobulin in the treatment of spontaneously acquired factor VIII inhibitors.
- Significance of axillary lymph node extranodal Soft tissue extension and indications for postmastectomy irradiation.
- CT number distribution and its association with local control and as a marker of Lung tumor response to radiation.
- Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast Cancer.
- Post-mastectomy radiation in male breast Cancer.
- Radiation therapy in the management of patients with Malignant carcinoid tumors.
- Intensified adjuvant combined modality therapy for resected periampullary adenoCarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
- Radiation-mediated control of drug deLivery.
- Targeting drug deLivery to radiation-induced neoantigens in tumor microvasculature.
- A phase I trial of outpatient weekly irinotecan/carboplatin and concurrent radiation for stage III unresectable non small-cell lung Cancer: a Vanderbilt-Ingram Cancer ...
- Intensified adjuvant therapy for pancreatic and periampullary adenoCarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA...
- The role of radiation, with or without chemotherapy, in the management of NSCLC.
- Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.
- A pilot study of neoadjuvant paclitaxel and radiation with correlative molecular studies in stage II/III breast Cancer.
- Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast Cancer: initial results.
- Early Prediction of the Response of Breast Tumors to Neoadjuvant Chemotherapy using Quantitative MRI and Machine Learning.
- A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast Cancer.
- p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage.
- Identification of human triple-negative breast Cancer subtypes and preclinical models for selection of targeted therapies.
- Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with Anal cancer (ECOG E4292).
- Motion correction in diffusion-weighted MRI of the Breast at 3T.
- Preoperative concurrent paclitaxel-radiation in locally advanced breast Cancer: pathologic response correlates with five-year overall survival.
- Validation of an algorithm for the nonrigid registration of longitudinal Breast MR images using realistic phantoms.
- A phase I study of bortezomib in combination with standard 5-fluorouracil and external-beam radiation therapy for the treatment of locally advanced or metastatic recta...
- Esophageal adenoCarcinoma: treatment modalities in the era of targeted therapy.
- Identification of markers of taxane sensitivity using proteomic and genomic Analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.
- Temporal sampling requirements for reference region modeling of DCE-MRI data in human breast Cancer.
- A nonrigid registration algorithm for longitudinal breast MR images and the Analysis of breast tumor response.
- SU11248 (sunitinib) sensitizes pancreatic Cancer to the cytotoxic effects of ionizing radiation.
- Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic Cancer: a multicenter phase II trial.
- Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast Cancer.
- Radiation therapy for non-small cell lung Cancer (NSCLC).
Schools
George Washington University School of Medicine And Health Sciences
Mayo Clinic Rochester
University MD Canc Center
Johns Hopkins University
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Radiation Oncology
Accepted Insurances
- Aetna
- American Republic
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Network S
- Bluegrass Family Health
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care of Tennessee PPO
- GEHA
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- POMCO Group
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- WellCare
Awards
- America's Top Doctors
- Nashville Lifestyles Magazine
- America's Top Doctors for Cancer
Education
-
Johns Hopkins University -
University of Maryland -
Mayo School of Graduate Medical Education -
George Washington University School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics -
Williamson Medical Center
Drug Facts
| NPI NUMBER | 1164506275 | |
| NPPES Provider LastName | CHAKRAVARTHY | |
| NPPES Provider FirstName | ANURADHA | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 310.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 5.16 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164506275 |
| Last Name Of The Provider | CHAKRAVARTHY |
| First Name Of The Provider | ANURADHA |
| View All |
Similar Doctors
|
|
Dr. Kenneth M. Lloyd, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony J. Cmelak, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Julian C. Heitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles E. McKay, MD |
|
|
Dr. Melissa L. Johnson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clayton A. Smith, MD |